Junyan T. Wu

107 Yanjiang West Road
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Correction: Chloral hydrate alters brain activation induced by methamphetamine-associated cue and prevents relapse.

Correction: Chloral hydrate alters brain activation induced by methamphetamine-associated cue and prevents relapse.

Journal: Frontiers in molecular neuroscience

Published: June 01, 2026

Development and Validation of a Rapid Benefit-Risk Assessment Index for Pediatric Off-Label Drug Use.

Development and Validation of a Rapid Benefit-Risk Assessment Index for Pediatric Off-Label Drug Use.

Journal: Journal of evidence-based medicine

Published: January 23, 2026

Epidemiological trends, risk factor contributions, and future projections of cardiovascular disease among Chinese adults ≥45 years: insights from GBD 2021 and CHARLS.

Epidemiological trends, risk factor contributions, and future projections of cardiovascular disease among Chinese adults ≥45 years: insights from GBD 2021 and CHARLS.

Journal: Experimental gerontology

Published: January 20, 2026

Development of a real-world, therapeutic drug monitoring-informed model to predict teicoplanin daily dose in pediatric intensive care unit patients with bacterial infections.

Development of a real-world, therapeutic drug monitoring-informed model to predict teicoplanin daily dose in pediatric intensive care unit patients with bacterial infections.

Journal: International journal of clinical pharmacy

Published: January 06, 2026

Advancing pharmacist involvement in surgical prehabilitation: a call to action for global pharmacy practice.

Advancing pharmacist involvement in surgical prehabilitation: a call to action for global pharmacy practice.

Journal: International journal of clinical pharmacy

Published: October 25, 2025

Short-term effect of iodine contrast medium on thyroid function: a prospective cohort study.

Short-term effect of iodine contrast medium on thyroid function: a prospective cohort study.

Journal: Annals of medicine

Published: September 18, 2025

Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition).

Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition).

Journal: Translational pediatrics

Published: August 04, 2025

Patient Version of Guideline for Fibromyalgia (2025 Edition).

Patient Version of Guideline for Fibromyalgia (2025 Edition).

Journal: Journal of evidence-based medicine

Published: June 17, 2025

Risk of Ophthalmotoxicity Associated with Antibody-Drug Conjugates: A Systematic Review and Meta-analysis.

Risk of Ophthalmotoxicity Associated with Antibody-Drug Conjugates: A Systematic Review and Meta-analysis.

Journal: Clinical drug investigation

Published: April 24, 2025

Safety profile of nivolumab-relatlimab in cancer patients: a living pharmacovigilance study of clinical trials and postmarketing data (version 1.0).

Safety profile of nivolumab-relatlimab in cancer patients: a living pharmacovigilance study of clinical trials and postmarketing data (version 1.0).

Journal: European journal of pharmacology

Published: April 10, 2025

Ophthalmotoxicity induced by antibody-drug conjugates: a pharmacovigilance study of the FDA adverse event reporting system (FAERS).

Ophthalmotoxicity induced by antibody-drug conjugates: a pharmacovigilance study of the FDA adverse event reporting system (FAERS).

Journal: Expert opinion on drug safety

Published: April 09, 2025

Single- and multiple-dose pharmacokinetics and safety of the SARS-CoV-2 3CL protease inhibitor RAY1216: a phase 1 study in healthy participants.

Single- and multiple-dose pharmacokinetics and safety of the SARS-CoV-2 3CL protease inhibitor RAY1216: a phase 1 study in healthy participants.

Journal: Antimicrobial agents and chemotherapy

Published: January 31, 2025

Showing 1-12 of 73

Last Updated: 09/26/2026